178 related articles for article (PubMed ID: 36996377)
41. A Comprehensive Understanding of the Genomic Bone Tumor Landscape: A Multicenter Prospective Study.
Xie X; Bian Y; Li H; Yin J; Tian L; Jiang R; Zeng Z; Shi X; Lei Z; Hou C; Qu Y; Wang L; Shen J
Front Oncol; 2022; 12():835004. PubMed ID: 35756627
[TBL] [Abstract][Full Text] [Related]
42. Age-dependent molecular variations in osteosarcoma: implications for precision oncology across pediatric, adolescent, and adult patients.
Zou C; Huang R; Lin T; Wang Y; Tu J; Zhang L; Wang B; Huang J; Zhao Z; Xie X; Huang G; Wang K; Yin J; Shen J
Front Oncol; 2024; 14():1382276. PubMed ID: 38841159
[TBL] [Abstract][Full Text] [Related]
43. Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer.
Hamid AA; Gray KP; Shaw G; MacConaill LE; Evan C; Bernard B; Loda M; Corcoran NM; Van Allen EM; Choudhury AD; Sweeney CJ
Eur Urol; 2019 Jul; 76(1):89-97. PubMed ID: 30553611
[TBL] [Abstract][Full Text] [Related]
44. Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group.
Shulman DS; Klega K; Imamovic-Tuco A; Clapp A; Nag A; Thorner AR; Van Allen E; Ha G; Lessnick SL; Gorlick R; Janeway KA; Leavey PJ; Mascarenhas L; London WB; Vo KT; Stegmaier K; Hall D; Krailo MD; Barkauskas DA; DuBois SG; Crompton BD
Br J Cancer; 2018 Aug; 119(5):615-621. PubMed ID: 30131550
[TBL] [Abstract][Full Text] [Related]
45. Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients.
Harting MT; Lally KP; Andrassy RJ; Vaporciyan AA; Cox CS; Hayes-Jordan A; Blakely ML
J Cancer Res Clin Oncol; 2010 Apr; 136(4):561-70. PubMed ID: 19784847
[TBL] [Abstract][Full Text] [Related]
46. CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in patients with osteosarcoma.
Iwata S; Tatsumi Y; Yonemoto T; Araki A; Itami M; Kamoda H; Tsukanishi T; Hagiwara Y; Kinoshita H; Ishii T; Nagase H; Ohira M
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036394
[TBL] [Abstract][Full Text] [Related]
47. Genome-wide analyses on high-grade osteosarcoma: making sense of a genomically most unstable tumor.
Kuijjer ML; Hogendoorn PC; Cleton-Jansen AM
Int J Cancer; 2013 Dec; 133(11):2512-21. PubMed ID: 23436697
[TBL] [Abstract][Full Text] [Related]
48. DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma.
Tarkkanen M; Elomaa I; Blomqvist C; Kivioja AH; Kellokumpu-Lehtinen P; Böhling T; Valle J; Knuutila S
Int J Cancer; 1999 Apr; 84(2):114-21. PubMed ID: 10096241
[TBL] [Abstract][Full Text] [Related]
49. A Comparison of Outcomes and Prognostic Features for Radiation-Associated Angiosarcoma of the Breast and Other Radiation-Associated Sarcomas.
Mito JK; Mitra D; Barysauskas CM; Mariño-Enriquez A; Morgan EA; Fletcher CDM; Raut CP; Baldini EH; Doyle LA
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):425-435. PubMed ID: 30703514
[TBL] [Abstract][Full Text] [Related]
50. Translational cell biology of highly malignant osteosarcoma.
Roessner A; Lohmann C; Jechorek D
Pathol Int; 2021 May; 71(5):291-303. PubMed ID: 33631032
[TBL] [Abstract][Full Text] [Related]
51. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.
Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G
Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260
[TBL] [Abstract][Full Text] [Related]
52. Gene expression profiling of canine osteosarcoma reveals genes associated with short and long survival times.
Selvarajah GT; Kirpensteijn J; van Wolferen ME; Rao NA; Fieten H; Mol JA
Mol Cancer; 2009 Sep; 8():72. PubMed ID: 19735553
[TBL] [Abstract][Full Text] [Related]
53. Clinicopathologic features of osteosarcoma in patients with Rothmund-Thomson syndrome.
Hicks MJ; Roth JR; Kozinetz CA; Wang LL
J Clin Oncol; 2007 Feb; 25(4):370-5. PubMed ID: 17264332
[TBL] [Abstract][Full Text] [Related]
54. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
[TBL] [Abstract][Full Text] [Related]
55. Genome sequencing analysis of blood cells identifies germline haplotypes strongly associated with drug resistance in osteosarcoma patients.
Bhuvaneshwar K; Harris M; Gusev Y; Madhavan S; Iyer R; Vilboux T; Deeken J; Yang E; Shankar S
BMC Cancer; 2019 Apr; 19(1):357. PubMed ID: 30991985
[TBL] [Abstract][Full Text] [Related]
56. Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations.
Bousquet M; Noirot C; Accadbled F; Sales de Gauzy J; Castex MP; Brousset P; Gomez-Brouchet A
Ann Oncol; 2016 Apr; 27(4):738-44. PubMed ID: 26787232
[TBL] [Abstract][Full Text] [Related]
57. Case Report: Sequential Chemotherapy and Immunotherapy Produce Sustained Response in Osteosarcoma With High Tumor Mutational Burden.
Zheng S; Wang F; Huang J; Zhou Y; Yang Q; Qian G; Zhou C; Min D; Song L; Shen Z
Front Endocrinol (Lausanne); 2021; 12():625226. PubMed ID: 34220700
[TBL] [Abstract][Full Text] [Related]
58. Genetic and epigenetic alterations of the cell cycle regulators and tumor suppressor genes in pediatric osteosarcomas.
Patiño-García A; Piñeiro ES; Díez MZ; Iturriagagoitia LG; Klüssmann FA; Ariznabarreta LS
J Pediatr Hematol Oncol; 2003 May; 25(5):362-7. PubMed ID: 12759621
[TBL] [Abstract][Full Text] [Related]
59. Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion.
Saba KH; Cornmark L; Rissler M; Fioretos T; Åström K; Haglund F; Rosenberg AE; Brosjö O; Nord KH
Genes Chromosomes Cancer; 2019 Oct; 58(10):731-736. PubMed ID: 31066955
[TBL] [Abstract][Full Text] [Related]
60. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
